The appearance of hypodense eosinophils in antigen-dependent late phase asthma.

Although peripheral blood eosinophils (EOS) of low density are increased in patients with asthma, the mechanisms contributing to their presence are not well established. The following study evaluated the effect of an antigen bronchoprovocation (BP) on the percentage of circulating hypodense eosinophils (HE) in asthma. EOS density was measured by centrifugation of peripheral blood granulocytes over multiple discontinuous density Percoll gradients in samples taken immediately before and 24 h after antigen BP. We found that the percentage of peripheral blood HE (density less than 1.095 g/ml) increased significantly (p less than 0.02) over baseline values (78.9 +/- 4.8% versus 53.3 +/- 8.2%, mean +/- SEM, n = 11) when evaluated 24 h after antigen BP but only in patients who experienced both an immediate (IAR) and late phase asthma reaction (LAR). No significant change in the percentage of HE was observed in asthma subjects who had only an early asthma response to inhaled antigen (n = 6). In an expanded population of allergic asthmatics (n = 38), a significant correlation was found between the percent peripheral blood HE and disease severity as represented by the percent predicted FEV1 (r = -0.56, p = 0.003). These data suggest that in vivo activation of asthma by inhaled antigen increases the proportion of peripheral blood EOS that are hypodense but only in those patients with both an IAR and LAR. Furthermore, we also conclude that the percentage of HE better reflects the severity of asthma than the concentration of total peripheral blood eosinophils.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  W. Owen,et al.  Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3. , 1988, The Journal of clinical investigation.

[2]  A. Wardlaw,et al.  Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. , 1988, The American review of respiratory disease.

[3]  W. Owen,et al.  Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts , 1987, The Journal of experimental medicine.

[4]  P. Venge,et al.  Eosinophil activation in allergic disease. , 1987, International archives of allergy and applied immunology.

[5]  J. Dipersio,et al.  Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor. , 1986, Journal of immunology.

[6]  S. Durham,et al.  Leukocyte activation in allergen-induced late-phase asthmatic reactions. , 1984, The New England journal of medicine.

[7]  S. Peters,et al.  Arachidonic acid metabolism in purified human lung mast cells. , 1984, Journal of immunology.

[8]  A. Capron,et al.  Role of IgE receptors in effector function of human eosinophils. , 1984, Journal of immunology.

[9]  I. Olsson,et al.  Altered density, metabolism and surface receptors of eosinophils in eosinophilia. , 1982, Immunology.

[10]  N. Thomson,et al.  Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway caliber. , 1982, The Journal of allergy and clinical immunology.

[11]  M. Lebowitz,et al.  Epidemiologic observations on eosinophilia and its relation to respiratory disorders. , 2015, The American review of respiratory disease.

[12]  U. Ryo,et al.  Bronchial sensitivity to methacholine in current and former asthmatic and allergic rhinitis patients and control subjects. , 1975, The Journal of allergy and clinical immunology.